Cite
Meta-analysis derived atopic dermatitis (MADAD) transcriptome defines a robust AD signature highlighting the involvement of atherosclerosis and lipid metabolism pathways.
MLA
Ewald, David A., et al. “Meta-Analysis Derived Atopic Dermatitis (MADAD) Transcriptome Defines a Robust AD Signature Highlighting the Involvement of Atherosclerosis and Lipid Metabolism Pathways.” BMC Medical Genomics, vol. 8, Oct. 2015, pp. 1–15. EBSCOhost, https://doi.org/10.1186/s12920-015-0133-x.
APA
Ewald, D. A., Malajian, D., Krueger, J. G., Workman, C. T., Tianjiao Wang, Suyan Tian, Litman, T., Guttman-Yassky, E., & Suárez-Fariñas, M. (2015). Meta-analysis derived atopic dermatitis (MADAD) transcriptome defines a robust AD signature highlighting the involvement of atherosclerosis and lipid metabolism pathways. BMC Medical Genomics, 8, 1–15. https://doi.org/10.1186/s12920-015-0133-x
Chicago
Ewald, David A., Dana Malajian, James G. Krueger, Christopher T. Workman, Tianjiao Wang, Suyan Tian, Thomas Litman, Emma Guttman-Yassky, and Mayte Suárez-Fariñas. 2015. “Meta-Analysis Derived Atopic Dermatitis (MADAD) Transcriptome Defines a Robust AD Signature Highlighting the Involvement of Atherosclerosis and Lipid Metabolism Pathways.” BMC Medical Genomics 8 (October): 1–15. doi:10.1186/s12920-015-0133-x.